Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    L-Lysine-d-amphetamine dimesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,922Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    17/01/2026 Alkem Laboratories
    India
    		 M/s Alkem Laboratories Ltd WC-0385 Lisdexamfetamine Dimesylate IH 2025-09-24 2028-09-23 Survey No. -85 to 88, N.H. No. 8, Naugama,At & Post-Mandva, Tal. -Ankleshwar, Dist.-Bharuch -393010, Gujarat, India
    01/12/2025 Embio Limited
    India
    		 M/s Embio Limited WC-0046 Lisdexamfetamine Dimesylate IH 2025-08-08 2028-07-28 E-21, MIDC, Indt. Estate, Mahad-402 309, Taluka: Mahad, District: Raigad, Maharashtra, India\r\n
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.